This federal Project Grant award of $202,314 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year research program to investigate the mechanisms of increased intestinal epithelial cell (IEC) barrier permeability in peanut allergy. The research will utilize a novel mouse model and primary human intestinal cell cultures to examine how alterations in the gut microbiome and IEC...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $6,732,986 to the Icahn School of Medicine at Mount Sinai to conduct a longitudinal study on the development of food allergy. The study aims to characterize the early-life trajectories of the oral environment, including immunology, microbial communities, and metabolites, and their relationship with the onset of...
This federal Project Grant award of $586,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the generation and regulation of TFH13 cells that drive pathogenic IgE in allergic conditions. The overarching goal is to elucidate the pathways leading to TFH13 cell differentiation, which play a critical...
This $797,735 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the cellular and molecular mechanisms governing heightened immune responses in neonates. The research project will utilize a novel mouse model to investigate how the innate immune system detects and mediates sterile inflammation during early life development, with the goal of developing targeted...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $202,245 in funding to Pennsylvania State University's Milton S. Hershey Medical Center to conduct research on the role of intestinal epithelial permeability and the aryl hydrocarbon receptor (AhR) in regulating immune tolerance in the gut. The 2-year project aims to 1) determine the mechanisms of reduced intestinal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $571,091 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to President and Fellows of Harvard College, doing business as Harvard Medical School, to investigate the role of gut regulatory T (Treg) cells and their interactions with the gut microbiome. The research aims to understand how microbial and food antigens establish gut Treg phenotypes and T cell receptor repertoires, particularly...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $300,000 in funding to Cellergy Pharma Inc. to develop a bispecific antibody therapy that can efficiently and specifically eliminate IgE-producing B cells without significant side effects. The goal is to achieve complete and durable suppression of allergic symptoms for severe allergic diseases affecting millions of...
This $751,138 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) supports research to determine how the metabolism of dendritic cells, a type of immune cell, regulates inflammatory immune responses. The central hypothesis is that the activity of the enzyme glutaminase in dendritic cells controls their ability to activate pro-inflammatory T cells versus regulatory T...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $101,577 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Michigan State University (MSU) to investigate the mechanisms by which early life adversity alters mast cell programming and inflammatory activity through modulation of cholesterol metabolism. The research aims to define how early life stress developmentally heightens the mast cell pro-inflammatory phenotype, which...
This federal Project Grant award of $828,775, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to study the role of food sensitization in the development of cardiovascular disease. The primary awardee, the University of North Carolina at Chapel Hill, will comprehensively assess the relationship between food-specific IgE antibodies and cardiovascular disease mortality,...
THE ROLE OF NEUROIMMUNE PATHWAYS IN FOOD ALLERGIES - SUMMARY FOOD ALLERGY AFFECTS MILLIONS OF PEOPLE WORLDWIDE AND THE PREVALENCE IS INCREASING RAPIDLY. UNFORTUNATELY, MANY ASPECTS OF THE MECHANISMS BEHIND FOOD ALLERGY ARE POORLY UNDERSTOOD, AND THUS TREATMENT OPTIONS ARE LIMITED. TO ENHANCE OUR UNDERSTANDING OF FOOD ALLERGY, THE FOOD ALLERGY SCIENCE INITIATIVE (FASI) WAS FOUNDED IN 2016 WITH THE GOAL OR UNDERSTANDING THE MECHANISM OF DISEASE IN FOOD ALLERGIES AND BRING THOSE INSIGHTS INTO THERAPEUTICS. FOOD ALLERGY IS TRADITIONALLY THOUGHT OF AS A MALFUNCTION OF THE IMMUNE SYSTEM. HOWEVER, IT HAS BECOME CLEAR THAT THE NERVOUS SYSTEM AND INTESTINAL EPITHELIUM ALSO PLAY AN IMPORTANT ROLE IN ALLERGIC DISEASE; THIS PROGRAM WILL USE AN INTEGRATIVE APPROACH TO INVESTIGATE THESE UNDERLYING PATHWAYS. OUR TEAM WILL EXPLORE THE HYPOTHESIS THAT FOOD ALLERGY IS AN EXAGGERATED OR MIS-TARGETED REACTION THAT NORMALLY AIMS TO PROTECT FROM HARMFUL SUBSTANCES PRESENT IN FOOD, INCLUDING NOXIOUS PHYTOCHEMICALS AND TOXINS. THIS IS BASED ON GROWING EVIDENCE INDICATING THAT NEURO-IMMUNE INTERACTIONS PLAY A FUNDAMENTAL ROLE IN FOOD ALLERGIES. FOR EXAMPLE, MANY MANIFESTATIONS OF FOOD ALLERGIES (VOMITING, DIARRHEA, ABDOMINAL PAIN, NAUSEA) INVOLVE COMBINED EFFECTS OF INFLAMMATORY MEDIATORS AND PARASYMPATHETIC REFLEXES. IN ADDITION, SENSORY INPUTS THROUGH THE VAGAL AFFERENTS AND DORSAL ROOT GANGLIA NEURONS DEDICATED TO MONITORING NOXIOUS INPUTS APPEAR TO BE RESPONSIVE TO ALLERGENS DETECTED BY THE IMMUNE SYSTEM. MULTIPLE RECIPROCAL INTERACTIONS BETWEEN THE TWO SYSTEMS COMPLEMENT EACH OTHER'S CAPACITIES SUCH THAT ANTIGEN-SPECIFIC ANTIBODIES PROVIDE INPUTS TO THE SENSORY NEURONS, LEADING TO THEIR PROCESSING IN THE CNS, AND NEURONAL CONTROL CIRCUITS COORDINATE OPTIMAL DEFENSE MODALITIES OF THE IMMUNE SYSTEM. CONVERSELY, THE NERVOUS SYSTEM HAS GREATER CAPACITY FOR EVALUATION OF ENVIRONMENTAL CUES AND THE INTERNAL STATE OF THE ORGANISM AND CAN USE ITS SUPERIOR INFORMATION PROCESSING CAPACITIES TO DICTATE THE OUTCOME OF IMMUNE RECOGNITION (TOLERANCE VERSUS SENSITIZATION) AND IMMUNE EFFECTOR FUNCTIONS. NEURO-IMMUNE COMMUNICATIONS IS A NASCENT FIELD AND THE PROGRAM WILL ADDRESS SOME OF THE FOUNDATIONAL QUESTIONS THAT WILL ILLUMINATE THE LOGIC OF THESE MECHANISMS AND HELP UNCOVER NEW TARGETS FOR THERAPEUTIC INTERVENTIONS. WE WILL FOCUS ON KEY QUESTIONS IN NEURO-IMMUNE INTERACTIONS THAT ARE RELEVANT FOR UNDERSTANDING FOOD ALLERGY. THIS WILL INCLUDE INVESTIGATION OF HOW MAST CELLS ORCHESTRATE EPITHELIAL AND NEURONAL RESPONSES (PROJECT 1), NEURONAL CIRCUITS ENGAGED ININ FOOD ALLERGY (PROJECT 2), AND MAPPING PHYSICAL INTERACTIONS BETWEEN EPITHELIAL, IMMUNE, AND NEURONAL CELLS INVOLVED IN DEVELOPMENT OF FOOD ALLERGY (PROJECT 3). ALL THREE PROJECTS WILL BE SUPPORTED BY BOTH THE TRANSGENIC CORE (CORE B) AND BIOINFORMATICS CORE (CORE C). THE POWER OF THIS PROGRAM TEAM IS THAT INVESTIGATORS WITH EXPERTISE IN MUCOSAL IMMUNOLOGY, NEUROBIOLOGY, AND ALLERGIC INFLAMMATION ARE COMING TOGETHER TO STUDY FOOD ALLERGEN RESPONSES, AND THE TEAM IS MUCH STRONGER THAN THE SUM OF ITS INDIVIDUAL PARTS. THE PROJECTS PROPOSED HERE WILL INCORPORATE INSIGHTS AND EXPERTISE FROM DIVERSE AND COMPLEMENTARY PERSPECTIVES FROM OUR INVESTIGATORS TO PROVIDE A COMPREHENSIVE ASSESSMENT OF HOW THE ENTERIC NERVOUS SYSTEM, THE CENTRAL NERVOUS SYSTEM, THE IMMUNE SYSTEM, AND INTESTINAL EPITHELIAL CELLS INTERACT TO REGULATE THE RESPONSES TO FOOD ALLERGY.